Ground reaction forces in locomoting hemi-parkinsonian rats: a definitive test for impairments and compensations.
Hemi-parkinsonian rats have preserved postural reflexes but are impaired in initiation of voluntary movements. Surprisingly, these rats can walk and run, suggesting that they can access some compensatory strategy to overcome the rigidity in their impaired limbs. The purpose of the present experiment was to investigate the locomotor compensations made by hemi-parkinsonian rats by measuring the forces exerted by the limbs on the ground throughout the stride during trotting. Rats with unilateral dopamine depletion produced by injection of 6-hydroxydopamine into the nigrostriatal bundle were trained to run back and forth in an alley for food reinforcement. Ground reaction forces were measured in three orthogonal directions using a force plate embedded in the runway. Rats were also videotaped so that limb movements were synchronized with force recordings. Although locomotion was obviously impaired, the affected limbs could support weight and provide some braking forces. In addition, the impaired hindlimb provided significant propulsive force, and a relatively large laterally directed force. Analysis of vertical movement of the centre of mass suggested that the impaired hindlimb was being used partly as a spring. The most significant abnormalities were seen during the diagonal couplet of the impaired forelimb and the unimpaired hindlimb, partly reflecting the important compensatory role of the unimpaired hindlimb. These results demonstrate that this method is useful in the analysis of hemi-parkinsonian gait and provide insights as to how rats can use an impaired limb to produce weight support and propulsion.
Muir
G D
GD
Department of Veterinary Physiological Sciences, University of Saskatchewan, Saskatooon, Canada. muir@admin3.usask.ca
Whishaw
I Q
IQ
D000222:Adaptation, Physiological / Q000502:physiology*; D000818:Animals; D003342:Corpus Striatum / Q000378:metabolism / Q000503:physiopathology; D004298:Dopamine / Q000172:deficiency; D005121:Extremities / Q000503:physiopathology; D005260:Female; D005684:Gait / Q000502:physiology; D006112:Gravitation; D009043:Motor Activity / Q000502:physiology*; D016627:Oxidopamine / Q000494:pharmacology; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000503:physiopathology*; D051381:Rats; D020318:Rats, Long-Evans; D012016:Reference Values; D013378:Substantia Nigra / Q000187:drug effects / Q000503:physiopathology
D016627:Oxidopamine; D004298:Dopamine